← Back to Search

Behavioral Intervention

Tech-PN for Pelvic Inflammatory Disease

N/A
Waitlist Available
Led By Maria Trent, MD, MPH
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Mild-moderate PID
Outpatient treatment disposition
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial is testing a new way to provide support to young women with pelvic inflammatory disease, using technology-enhanced community health nursing intervention with an evidence-based STI prevention curriculum, to see if it reduces rates of repeat infection.

Who is the study for?
This trial is for young women aged 13-25 in the Baltimore area who have been diagnosed with mild to moderate pelvic inflammatory disease (PID) and are not pregnant. Participants must be willing to sign informed consent, agree to randomization, and be able to communicate and complete study procedures.Check my eligibility
What is being tested?
The trial is testing a new approach called TECH-PN which includes community health nurse visits and text message support for 30 days, plus additional field testing and treatment. It aims to improve adherence to PID treatment, reduce unprotected sex, prevent repeat STI infections, and evaluate cost-effectiveness against standard care.See study design
What are the potential side effects?
Since this intervention primarily involves nursing support and communication rather than medication or invasive procedures, significant side effects are not expected. However, there may be privacy concerns related to personal health data management.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My pelvic inflammatory disease is not severe.
Select...
I am receiving treatment without needing to stay in the hospital.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of STI Mycoplasma genitalium
Rate of STI Trichomonas vaginalis
Vaginal health as assessed by proportion of high Lactobacilli community state-type 1 properties (CST)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TECH-PNExperimental Treatment1 Intervention
Participants receive community health nurse visits, text-messaging support, additional testing and field based visits with a nurse practitioner.
Group II: TECH-NActive Control1 Intervention
Participants receive enhanced standard of care with community health nurse visits and text-messaging support.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,242 Previous Clinical Trials
14,816,657 Total Patients Enrolled
1 Trials studying Pelvic Inflammatory Disease
286 Patients Enrolled for Pelvic Inflammatory Disease
National Institute of Nursing Research (NINR)NIH
575 Previous Clinical Trials
10,355,337 Total Patients Enrolled
1 Trials studying Pelvic Inflammatory Disease
286 Patients Enrolled for Pelvic Inflammatory Disease
Maria Trent, MD, MPHPrincipal InvestigatorJohns Hopkins University
2 Previous Clinical Trials
386 Total Patients Enrolled
1 Trials studying Pelvic Inflammatory Disease
286 Patients Enrolled for Pelvic Inflammatory Disease

Media Library

Tech-PN (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03828994 — N/A
Pelvic Inflammatory Disease Research Study Groups: TECH-PN, TECH-N

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly individuals being admitted to this clinical trial?

"The team is searching for patients who have reached their teenage years, but are still younger than 25."

Answered by AI

Who is eligible for enrollment in this experiment?

"A clinical trial to test the efficacy of a new treatment for adnexitis is currently accepting participants between 13 and 25 years old. Approximately 150 volunteers are needed to properly assess this medication's effectiveness."

Answered by AI

Is enrollment currently underway for this experiment?

"Absolutely. According to information on clinicaltrials.gov, this research is currently open for patient enrollment and was originally listed on February 10th 2019. The updated date of the trial's listing is February 8th 2022 and it requires 150 participants from one site."

Answered by AI

How many individuals are participating in the current clinical trial?

"Affirmative, the clinicaltrials.gov platform indicates active recruitment for this medical study which was first posted on February 10th 2019 and has since had a most recent update on February 8th 2022. The research requires 150 participants to be distributed across one site."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
~19 spots leftby Dec 2024